Serum Institute of India founder to set aside 60,000 coronavirus vaccine doses for Parsis https://ift.tt/2WL4sH4
Serum Institute of India, which is manufacturing the coronavirus vaccine developed by Oxford University and AstraZeneca, will keep aside 60,000 doses of COVID-19 vaccine for Parsis. Serum Institute founder Cyrus Poonawalla, who is himself a Parsi has decided to set aside the doses of the under-trial vaccine.
Comments
Post a Comment